AutoImmune Inc. is a biopharmaceutical company developing a new class of orally administered products to treat autoimmune and other cell-mediated inflammatory diseases. Each of these products is based on a common biological mechanism known as oral tolerance, which provides tissue specific immunosuppression to control disease without toxicity or significant side effects.
